NasdaqGS - Delayed Quote USD

Mesa Laboratories, Inc. (MLAB)

99.62

-1.52

(-1.50%)

At close: April 18 at 4:00 PM EDT

Advanced Chart

Loading Chart for MLAB

9/21 12:03 PM

DELL

Previous Close 101.14
Open 100.52
Bid 99.12 x 100
Ask 100.24 x 200
Day's Range 99.54 - 103.32
52 Week Range 82.86 - 178.64
Volume 30,239
Avg. Volume 45,222
Market Cap (intraday) 537.355M
Beta (5Y Monthly) 0.82
PE Ratio (TTM) 586.00
EPS (TTM) 0.17
Earnings Date May 24, 2024
Forward Dividend & Yield 0.64 (0.64%)
Ex-Dividend Date May 31, 2024
1y Target Est 130.00

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

www.mesalabs.com

698

Full Time Employees

March 31

Fiscal Year Ends

Technology

Sector

Scientific & Technical Instruments

Industry

YTD Return

MLAB

4.77%

S&P 500

5.06%

1-Year Return

MLAB

40.96%

S&P 500

20.71%

3-Year Return

MLAB

60.18%

S&P 500

19.73%

5-Year Return

MLAB

54.61%

S&P 500

72.77%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MLAB

Mesa Laboratories, Inc.

99.62

-1.50%

Mkt Cap 537.355M